Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, $0.01 Par Value
-
Shares outstanding
-
22.7M
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
19.2M
-
Shares change
-
+657K
-
Total reported value, excl. options
-
$873M
-
Value change
-
+$29.4M
-
Put/Call ratio
-
1.75
-
Number of buys
-
90
-
Number of sells
-
-74
-
Price
-
$45.55
Significant Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) as of Q2 2022
196 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value as of Q2 2022.
LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.2M shares
of 22.7M outstanding shares and own 84.52% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.24M shares), Conestoga Capital Advisors, LLC (1.86M shares), VANGUARD GROUP INC (1.45M shares), Copeland Capital Management, LLC (1.21M shares), Ranger Investment Management, L.P. (895K shares), GENEVA CAPITAL MANAGEMENT LLC (857K shares), STATE STREET CORP (754K shares), DIMENSIONAL FUND ADVISORS LP (681K shares), CRAMER ROSENTHAL MCGLYNN LLC (461K shares), and GEODE CAPITAL MANAGEMENT, LLC (385K shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.